Tang Capital Management LLC 13F Holdings · Q2 2026
Tang Capital Management LLC reported 41 securities worth $2.20B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: AUPH (10.05%), SYRE (7.63%), MIRM (6.57%). Among its top 25 positions this quarter: 3 new, 6 added, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AUPH | AURINIA PHARMACEUTICALS INC | $221.4M | 10.05% | 13.0M | Added |
| 2 | SYRE | SPYRE THERAPEUTICS INC | $168.0M | 7.63% | 1.9M | Hold |
| 3 | MIRM | MIRUM PHARMACEUTICALS INC | $144.7M | 6.57% | 1.2M | Hold |
| 4 | KNSA | KINIKSA PHARMACEUTICALS INTL | $144.5M | 6.56% | 2.3M | Hold |
| 5 | CELC | CELCUITY INC | $137.5M | 6.25% | 1.3M | Added |
| 6 | CORT | CORCEPT THERAPEUTICS INC | $130.4M | 5.92% | 1.5M | Hold |
| 7 | PTCT | PTC THERAPEUTICS INC | $122.4M | 5.56% | 1.5M | Hold |
| 8 | LKFT | LAKEFRONT BIOTHERAPEUTICS NV | $113.5M | 5.16% | 3.8M | Hold |
| 9 | CAPR | CAPRICOR THERAPEUTICS INC | $98.7M | 4.48% | 4.1M | Added |
| 10 | TARS | TARSUS PHARMACEUTICALS INC | $98.7M | 4.48% | 1.6M | Added |
| 11 | SPY | STATE STR SPDR S&P 500 ETF T | $91.9M | 4.17% | 123,000 | Trimmed |
| 12 | ANAB | ANAPTYSBIO INC | $89.8M | 4.08% | 1.3M | Hold |
| 13 | IMCR | IMMUNOCORE HLDGS PLC | $84.1M | 3.82% | 2.6M | Hold |
| 14 | CMPS | COMPASS PATHWAYS PLC | $70.8M | 3.21% | 5.0M | Added |
| 15 | ANIP | ANI PHARMACEUTICALS INC | $58.6M | 2.66% | 707,500 | Hold |
| 16 | BNTX | BIONTECH SE | $43.7M | 1.99% | 470,000 | Hold |
| 17 | CMPX | COMPASS THERAPEUTICS INC | $39.4M | 1.79% | 18.0M | Added |
| 18 | PGEN | PRECIGEN INC | $36.6M | 1.66% | 6.4M | Hold |
| 19 | VRDN | VIRIDIAN THERAPEUTICS INC | $32.9M | 1.50% | 1.8M | Hold |
| 20 | NVCT | NUVECTIS PHARMA INC | $28.5M | 1.29% | 1.6M | New |
| 21 | DNTH | DIANTHUS THERAPEUTICS INC | $25.8M | 1.17% | 264,692 | Hold |
| 22 | FULC | FULCRUM THERAPEUTICS INC | $23.9M | 1.08% | 6.5M | New |
| 23 | AVIR | ATEA PHARMACEUTICALS INC | $22.4M | 1.02% | 4.8M | Hold |
| 24 | CBIO | CRESCENT BIOPHARMA INC. | $20.9M | 0.95% | 1.2M | Hold |
| 25 | NNDM | NANO DIMENSION LTD | $20.7M | 0.94% | 14.3M | New |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR